Cargando…

Chloroquine dosage regimens in patients with COVID-19: Safety risks and optimization using simulations

Currently no specific medicinal treatment exists against the new SARS-CoV2 and chloroquine is widely used, since it can decrease the length of hospital stay and improve the evolution of the associated COVID-19 pneumonia. However, several safety concerns have been raised from chloroquine use due to t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Karalis, Vangelis, Ismailos, George, Karatza, Eleni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7241328/ https://www.ncbi.nlm.nih.gov/pubmed/32501367 http://dx.doi.org/10.1016/j.ssci.2020.104842

Ejemplares similares

Safety concerns with higher dosage chloroquine in COVID-19 patients
Publicado: (2020)

Correlation between Acinetobacter baumannii Resistance and Hospital Use of Meropenem, Cefepime, and Ciprofloxacin: Time Series Analysis and Dynamic Regression Models
por: Kousovista, Rania, et al.
Publicado: (2021)

3D-Printed Oral Dosage Forms: Mechanical Properties, Computational Approaches and Applications
por: Karalia, Danae, et al.
Publicado: (2021)

An In Vitro–In Vivo Simulation Approach for the Prediction of Bioequivalence
por: Vlachou, Marilena, et al.
Publicado: (2021)

A Literature Review of Pathophysiology, Clinical Manifestations, Medications and Optimal Dosage, Outpatient, and Post-hospitalization Use of Anticoagulation in COVID-19 Patients
por: Velissaris, Dimitrios, et al.
Publicado: (2023)

Risks of chloroquine or hydroxychloroquine use for COVID-19
Publicado: (2020)

Safety considerations for chloroquine and hydroxychloroquine in the treatment of COVID-19
por: Gevers, S., et al.
Publicado: (2020)

Recent Findings on Cardiovascular Safety With the Use of Chloroquine and Hydroxychloroquine for COVID-19
por: Guzman-Prado, Yuli
Publicado: (2020)

Safety considerations of chloroquine in the treatment of patients with diabetes and COVID-19
por: Gao, Xiuge, et al.
Publicado: (2022)

Of chloroquine and COVID-19
por: Touret, Franck, et al.
Publicado: (2020)

Pharmacokinetics of Doripenem in Healthy Koreans and Monte Carlo Simulations to Explore Optimal Dosage Regimens in Patients With Normal and Enhanced Renal Function
por: Kim, So Won, et al.
Publicado: (2018)

Optimal Teicoplanin Dosage Regimens in Critically Ill Patients: Population Pharmacokinetics and Dosing Simulations Based on Renal Function and Infection Type
por: Wang, Yifan, et al.
Publicado: (2023)

Chloroquine Dosing Recommendations for Pediatric COVID‐19 Supported by Modeling and Simulation
por: Verscheijden, Laurens F. M., et al.
Publicado: (2020)

A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19
por: Cortegiani, Andrea, et al.
Publicado: (2020)

Hydroxychloroquine and chloroquine retinal safety concerns during COVID-19 outbreak
por: Nicolò, Massimo, et al.
Publicado: (2020)

Hydroxychloroquine and chloroquine for COVID-19: psychiatric aspects of patient safety considerations
por: Biswas, Partha Sarathi, et al.
Publicado: (2020)

Chloroquine and hydroxychloroquine increase risk of death in COVID-19
Publicado: (2020)

Assessment of Micafungin Dosage Regimens in Patients with Cancer Using Pharmacokinetic/Pharmacodynamic Modeling and Monte Carlo Simulation
por: Alqahtani, Saeed, et al.
Publicado: (2021)

Chloroquine for COVID-19 Infection
por: Moore, Nicholas
Publicado: (2020)

Chloroquine, hydroxychloroquine and COVID-19
por: Erickson, T. B., et al.
Publicado: (2020)

Combating COVID-19 with Chloroquine
por: Hong, Wanjin
Publicado: (2020)

Treating COVID-19 with Chloroquine
por: Huang, Mingxing, et al.
Publicado: (2020)

Pretomanid dose selection for pulmonary tuberculosis: An application of multi‐objective optimization to dosage regimen design
por: Lyons, Michael A.
Publicado: (2021)

Optimization of the dosage regimen of zoledronic acid with a kinetic-pharmacodynamic model and exposure-response analysis
por: Wang, Huan, et al.
Publicado: (2023)

A physiologically based pharmacokinetic model to optimize the dosage regimen and withdrawal time of cefquinome in pigs
por: Mi, Kun, et al.
Publicado: (2023)

COVID-19, Chloroquine Repurposing, and Cardiac Safety Concern: Chirality Might Help
por: Lentini, Giovanni, et al.
Publicado: (2020)

Chloroquine, hydroxychloroquine, and COVID-19: Systematic review and narrative synthesis of efficacy and safety
por: Takla, Michael, et al.
Publicado: (2020)

Efficacy and Safety of Anti-malarial Drugs (Chloroquine and Hydroxy-Chloroquine) in Treatment of COVID-19 Infection: A Systematic Review and Meta-Analysis
por: Das, Rashmi Ranjan, et al.
Publicado: (2020)

An In Silico Approach toward the Appropriate Absorption Rate Metric in Bioequivalence
por: Karalis, Vangelis D.
Publicado: (2023)

Chloroquine and hydroxychloroquine in the context of COVID-19
por: Shukla, Ashutosh M, et al.
Publicado: (2020)

Chloroquine or hydroxychloroquine for prophylaxis of COVID-19
por: Principi, Nicola, et al.
Publicado: (2020)

Joint use of population pharmacokinetics and machine learning for optimizing antiepileptic treatment in pediatric population
por: Damnjanović, Ivana, et al.
Publicado: (2023)

Population-based meta-analysis of chloroquine: informing chloroquine pharmacokinetics in COVID-19 patients
por: Yao, Xueting, et al.
Publicado: (2020)

Comparison of the Cumulative Efficacy and Safety of Chloroquine, Artesunate, and Chloroquine-Primaquine in Plasmodium vivax Malaria
por: Chu, Cindy S, et al.
Publicado: (2018)

The Mechanism, Clinical Efficacy, Safety, and Dosage Regimen of Atomoxetine for ADHD Therapy in Children: A Narrative Review
por: Fu, Di, et al.
Publicado: (2022)

Research Progress of Chloroquine and Hydroxychloroquine on the COVID-19 and Their Potential Risks in Clinic Use
por: Chen, Yan, et al.
Publicado: (2020)

Update I. A systematic review on the efficacy and safety of chloroquine/hydroxychloroquine for COVID-19
por: Cortegiani, Andrea, et al.
Publicado: (2020)

Evaluation of the efficacy and safety of hydroxychloroquine in comparison with chloroquine in moderate and severe patients with COVID-19
por: Li, Qiuyu, et al.
Publicado: (2021)

Systematic review and meta-analysis of efficacy and safety of hydroxychloroquine and chloroquine in the treatment of COVID-19
por: Mittal, Niti, et al.
Publicado: (2021)

Failure of Supervised Chloroquine and Primaquine Regimen for the Treatment of Plasmodium vivax in the Peruvian Amazon
por: Graf, Paul C. F., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_fcbp59moae8qrh4rj4ka2q0nn8